Georgia State University

ScholarWorks @ Georgia State University
Chemistry Theses

Department of Chemistry

8-8-2017

Biophysical Heme Binding Studies of Corynebacterium
diphtheriae and Streptococcus pyogenes
Stephanie Thompson
sthompson60@student.gsu.edu

Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_theses

Recommended Citation
Thompson, Stephanie, "Biophysical Heme Binding Studies of Corynebacterium diphtheriae and
Streptococcus pyogenes." Thesis, Georgia State University, 2017.
doi: https://doi.org/10.57709/10492697

This Thesis is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia
State University. It has been accepted for inclusion in Chemistry Theses by an authorized administrator of
ScholarWorks @ Georgia State University. For more information, please contact scholarworks@gsu.edu.

BIOPHYSICAL HEME BINDING STUDIES OF CORYNEBACTERIUM DIPHTHERIAE
AND STREPTOCOCCUS PYOGENES

by

STEPHANIE SOPHIA THOMPSON
Under the Direction of Dabney K. W. Dixon, PhD
ABSTRACT
Gram-positive pathogenic bacteria utilize cell-surface anchored proteins to bind and
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hemoglobin. Proteins like HmuT from Corynebacterium diphtheriae bind and help transport
heme into the cell. Residues His136 and Tyr235 are utilized as the axial ligands, with a
conserved Arg237 residue acting as the hydrogen bonding partner to the axial Tyr235. Similarly,
Streptococcus pyogenes utilizes the cell anchored protein Shr to transfer heme into the cell. ShrNEAT2 is hexacoordinated by two axial methionines and is prone to autoreduction where lysines
are the most likely source of electrons. Lastly, PefR of Group A Streptococcus is a DNA
transcription factor which regulates protein expression. Preliminary studies indicate a cysteine
may coordinate the heme. A combination of UV-visible, resonance Raman, and magnetic
circular dichroism spectroscopies shows these proteins play a crucial role heme transport and
regulation.
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1.1

CHAPTER 1: INTRODUCTION TO HEME UPTAKE IN BACTERIA

Heme and Bacterial Virulence
Iron is a micronutrient necessary for the survival of many pathogenic organisms and is

required for bacterial virulence 1-3. Although abundant in nature, free iron is often inaccessible
in biological systems. Bacterial species have developed different systems to take up heme in
iron-depleted environments. One mechanism involves direct contact between the bacterium and
the iron sources. Another mechanism is dependent on the synthesis of molecules, referred to as
siderophores and/or hemophores, to be secreted by the bacterium to sequester iron from
exogenous sources 4.
The most abundant iron sources in biological systems are found in the form of heme.
Heme is a cofactor with an iron atom in the center of a protoporphyrin ring. Protoporphyrin rings
are composed of four pyrrole rings linked together by a variation of methine (=CH−) bridges,
methyl groups, vinyl groups, and propionic acid side chains. The iron atom in the center of the
ring can be found in the ferric (Fe3+) or ferrous (Fe2+) state. There are four major types of
biologically relevant hemes: heme A, heme B, heme C, and heme O. Heme B, the most
common, is iron protoporphyrin itself (Figure 1.1).

Figure 1.1 Structure of heme b.
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Structurally, heme A contains a methyl side chain at position eight of the protoporphyrin
ring oxidized to a formyl group and an isoprenoid chain group attached to one of the vinyl side
chains. Heme C differs by two covalent thioester linkages to the apoprotein through the vinyl
groups. Heme O has a methyl group at position eight instead of a formyl group. Heme is found
in proteins such as hemoglobin, the oxygen-transport metalloprotein in red blood cells5-7.
Bacterial virulence often determines the pathogenicity of an organism. Pathogens are
becoming increasingly more resistant to commonly used antibiotics 8. Bacterial cells, which
have developed resistance, continue to multiply, resulting in a resistant population that is then
transmitted from person to person. Bacteria use different biochemical mechanisms to counter
antibiotic pressure: antibiotic-degrading enzymes, antibiotic-altering enzymes, and antibiotic
efflux pumps. Alternatively, eliminating the nutritional sources of these pathogens, such as iron
in the form of heme, could be effective in deterring the growth of these bacteria. Therefore,
heme uptake studies in pathogenic bacteria may allow development of an alternative approach to
combat antibiotic resistance.
1.2

Heme Uptake in Gram-positive Bacteria
The heme uptake systems of gram-positive bacteria have been described in Bacillus

anthracis 9, Staphylococcus aureus 10, 11, Streptococcus pyogenes 12, 13, and Corynebacterium
species 14, 15. Gram-positive bacteria possess a thick cell wall formed by a peptidoglycan layer;
composed of glycopolymers, teichoic acids, and carbohydrates 16. Anchored to the cell wall are
proteins which shuttle heme from an extracellular source into the cell via ATP-binding cassette
(ABC) transporters. ABC transporter proteins are highly conserved membrane proteins that use
energy derived from the hydrolysis of ATP to drive transport of compounds across the lipid
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bilayer 17. ABC transporters can be classified into either importers or exporters. Importers
catalyze the uptake of molecules. They have low substrate affinity and therefore associate with
the periplasmic bound proteins that serve as primary binding sites due to their high affinity for
substrates. Exporters get rid of toxic materials and waste products. They recruit their substrates
directly 17. Heme binds to either the surface of these proteins or is scavenged by hemophores.
The heme is then transferred along a protein pathway to reach the intracellular environment.
Once inside the cell, heme oxygenase catalyzes the degradation of the heme moiety resulting in
the release of the iron 18, 19. The focus of this thesis will be on the mechanistic features of
specific heme uptake proteins from the bacterial pathogens Corynebacterium diphtheriae and S.
pyogenes.
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CHAPTER 2: HYDROGEN BONDING PARTNER HMUT R237A OF
CORYNEBACTERIUM DIPHTHERIAE

2.1

Heme Uptake in Corynebacterium diphtheriae
Corynebacterium diphtheriae is a gram-positive bacterial pathogen, the causative

organism of diphtheria, a severe upper respiratory tract infection in humans 14. Diphtheria is
widespread in third world countries lacking resources for proper vaccination 20. The ability of
pathogenic bacteria such as C. diphtheriae to obtain iron during infection is essential for
virulence 21. To date, pathogenic bacterial heme uptake pathways that have been characterized in
detail involve ATP-binding cassette (ABC) transporters, shown in Figure 2.1.
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Figure 2.1 Heme uptake system in Corynebacterium diphtheriae.

Three genes hmuT, hmuU, and hmuV in C. diphtheriae code for one of the ABC-type heme
transporters responsible for transporting heme into the cell 14. HmuU and HmuV are the
permease and ATPase components, respectively. HmuT has been shown to be a hemin binding
lipoprotein anchored to the cytoplasmic membrane by an N-terminal lipid moiety and is
responsible for transporting heme to the ABC transporter HmuUV. Homology modeling, UVvisible spectroscopy, resonance Raman spectroscopy, and magnetic circular dichroism suggested
that the conserved His136 and Tyr235 residues serve as the heme axial ligands (Figure 2.2) 22.
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Figure 2.2 I-TASSER model of WT HmuT from C. diphtheriae with conserved residues
indicated (His136 and Tyr235) and potential hydrogen bonding partners Arg237 and Tyr272.

2.2

Proposed Hydrogen Bonding Partners in Heme Uptake Pathways
The factors that cause heme uptake and release are of significance in understanding heme

transfer in pathogenic bacteria. One possibility for control of this process involves changes in
the hydrogen bonding to the heme or its axial ligands. The sections below review aspects of
literature studies on hydrogen bonding to residues involved in heme binding in the pocket of
various heme proteins.
2.2.1 Tyrosine as a Hydrogen Bonding Partner
Bacillus anthracis is a gram-positive bacterium that is the causative agent of anthrax. B.
anthracis secretes a hemophore, IsdX1, to acquire heme from host hemoglobin and enhance
bacterial replication in iron-starved environments 23. IsdX1 then transports the bound heme to
the surface protein IsdC where it is carried into the cell. The crystal structure of IsdX1 revealed
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the heme is by the axial ligand residue Tyr136, which forms a hydrogen bond with the phenolate
oxygen of Tyr140, with a distance of 2.3 Å.
2.2.2 Arginine as a Hydrogen Bonding Partner
Pseudomonas aeruginosa utilizes the periplasmic binding protein PhuT, required to
shuttle heme from the outer membrane to the inner membrane of the cell 24. The heme of PhuT
is embedded in a cleft between the N- and C-terminal domains and is coordinated by Tyr71 from
the C-terminus, as the heme ligand 24. An arginine in the proximal pocket (Arg73) hydrogenbonds to the axial tyrosinate ligand. The distance between the bonding sites of the two residues
is 4.3 Å, somewhat long for a classical hydrogen bond.
2.2.3 Histidine as a Hydrogen Bonding Partner
Serratia marcescens is a gram-negative bacterium and is responsible for many hospitalacquired infections in the United States 25-27. This pathogen obtains the iron from hemoglobin
through the secretion of the hemophore HasA28, 29. HasA takes up the heme from hemoglobin
and shuttles it to the receptor HasR, which in turn, releases heme into the bacterium 30. The axial
ligands were determined to be His32 and Tyr75 30. The phenolate group of Tyr75 has an
YxxxxxxxH motif and is thought to be involved in a hydrogen bond with His83. The distance
between those two residues is 2.7 Å.
2.2.4 Lysine as a Hydrogen Bonding Partner
Shigella dysenteriae is a gram-negative bacterium that resides in the human
gastrointestinal tract. This pathogen causes an inflammatory disorder of the lower digestive tract
in humans. S. dysenteriae encodes a periplasmic binding protein, ShuT, required to shuttle heme
from the outer membrane to the inner membrane 31, 32. The heme-ShuT complex contains a fivecoordinate high-spin heme that is linked to the protein through a proximal Fe3+-O bond to the
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phenolate side chain of Tyr67 32. It is also proposed that Tyr228 of ShuT may make a significant
contribution to the stability of heme-loaded ShuT, without directly interacting with the heme iron
32

. The crystal structure showed the axial Tyr67 reorients itself when heme is introduced. Tyr67

can point “in” toward the heme pocket, in the position to coordinate the heme iron, or flip out to
the surface 32. For the partially holo crystals, Tyr67 points inward; in the apo crystal, Tyr67 is
shown to point outward. Thus there is considerable flexibility in the orientation of Tyr67. The
change in conformation of the axial ligand may contribute to hydrogen-bonding to Lys69 32.
2.3

Axial Tyrosine Hydrogen Bonding Partner in Heme Transport Proteins
The majority of proteins in heme transport pathways studied to date utilize tyrosine as an

axial ligand 1, 3, 9, 16, 33-35. The axial tyrosine is thought to be found in the tyrosinate form, which
in turn, keeps the heme iron in the Fe3+ state, resulting in a low reduction potential due to thus
favored interaction36-38. Most tyrosine-ligated hemes have an additional residue near the pocket
which hydrogen bonds to the heme. Altering hydrogen bonding to these axial tyrosines may play
a role in triggering heme uptake and release. This interaction cannot be directly observed in
crystal structures of proteins. Many of these interactions are predicted based on homology
modeling or sequence alignment analyses. Mutations of these predicted hydrogen bonding
partners have served in many instances to show that the predicted interactions are indeed key in
proper stabilization of the bound heme. For C. diphtheriae HmuT, it is proposed that Arg237
hydrogen bonds to the axial tyrosine, Tyr235. The examples in literature of arginine residues
that hydrogen bond to the axial tyrosine are shown in Table 2.1.
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Table 2.1 Selected heme-binding proteins with corresponding residues which are
arginine hydrogen-bonded to the axial tyrosine ligand.

Protein

Y. pestis
HmuT
C. glutamicum
HmuT
C. diphtheriae
HmuT
C. diphtheriae
HmuT H136A
P. homomalla
cAOS
Bovine liver
catalase
M. avium ssp.
paratuberculo
sis MAP
i

Axial
Ligation

Residue
Hydrogen
Bonding
Axial
Tyrosine

Y70/H167

Motifa

Arg+Nω to
O-Tyr
(Å)

Arg+Nδ to
O-Tyr
(Å)

PDB

Reference

R72

YxR

2.8

3.8

3NU1

39

H141/Y240

R242

YxR

2.9

2.7

5AZ3

40

H136/Y235

R273i

YxR

3.0

2.9

-

41

Y235

R273i

YxR

2.9

3.0

-

41

Y353

R349

RxxxY

2.8

2.9

1U5U

42

Y357

R353

RxxxY

2.8

3.4

8CAT

43

Y294

R290

RxxxY

2.7

2.7

3E4Y

44

Residues that represent hydrogen bonding via homology modeling and spectroscopic studies

In Y. pestis and C. diphtheriae, HmuT hydrogen-bonds with an YxR motif; alternatively, for the
other bacteria models, tyrosine hydrogen bonds to arginine by utilizing an RxxxY motif.
2.4

Materials and Methods

2.4.1 DNA Extraction WT HmuT
The HmuT clone was a gift of Dr. Michael Schmitt. DNA extraction was performed using
the QIAprep Spin Miniprep Kit (50) from the company QIAGEN. A bacterial overnight culture
(5 mL) was pelleted by centrifugation at 10,000 rpm for 3 min at 15 °C. The bacterial pellet was
resuspended in 250 μL of Buffer P1 (50mM Tris-Cl, pH 8.0, 10mM EDTA, 100ug/mL RNase A)
and transferred to a microcentrifuge tube. Buffer P2 (200mM NaOH, 1% SDS), 250 μL, was
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added and mixed thoroughly. Buffer N3 (neutralization buffer) (350 μL) was immediately added
to the mixture. It was centrifuged for 15 min at 155,556 g at 15 °C. The supernatant was applied
to a QIAprep spin column. The column was washed with 750 μL of Buffer PE (wash buffer) and
transferred to a collection tube. The solution was centrifuged for 2 min at 155,556 g at 15 °C.
The flow-through was discarded and the spin column was placed in a clean microcentrifuge tube.
To elute the DNA, 50 μL of Buffer EB (10mM Tris-Cl, pH 8.5) was added to the spin column,
and was centrifuged for 1 min at 155,556 g at 15 °C.
2.4.2 HmuT R237 Mutation
Residue Arg237 was mutated to Ala237 via primers shown in Table 2.2.
Table 2.2Experimental Primer Data HmuT R237A

Oligo Name
HmuT R237A
Forward

MW
9340

Tm °C
80.2

Dimer
No

Secondary
Structure
Moderate

HmuT R237A
Reverse

9074

80.2

No

Moderate

GC%
53.3

DNA Sequence
GCATTTTTGTATGCGG
CGGGTAACGGTGGT

53.3

ACCACCGTTACCCGCC
GCATACAAAAATGC

Multiple reactions conditions were prepared and run on the PCR Eppendorf Mastercycler
Gradient. The reactions are shown in Table 2.3.
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Table 2.3 Reaction mixtures for PCR of HmuT R237A

Reaction mixture
Plasmid
(140 ng)
Forward Primer
[Rxn 1,2 (540 ng)]
[Rxn 3,4 (1000 ng)]
Reverse Primer
[Rxn 1,2 (540 ng)]
[Rxn 3,4 (1000 ng)]
dNTPmix (100 mM)
DMSO
[Rxn 1,3 (2%)]
[Rxn 2,4 (1% )]
10x Pfu Reaction
Buffer
Nanopure water
Pfu polymerase (2.5
U/µL) Agilent
Total reaction
volume

1

2

3

4

1 µL

1 µL

1 µL

1 µL

6 µL

6 µL

12 µL

12 µL

6 µL

6 µL

12 µL

12 µL

1 µL

1 µL

1 µL

1 µL

2.5 µL

1 µL

2.5 µL

1 µL

5 µL

5 µL

5 µL

5 µL

27.5 µL

29 µL

15.5 µL

17 µL

1 µL

1 µL

1 µL

1 µL

50 µL

50 µL

50 µL

50 µL

PCR was performed on the listed reactions using the “hot start” method. This included 18 cycles
of melting, annealing and extending (Table 2.4). After cycles were completed, the reactions
were held at 4 °C overnight.
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Table 2.4 Polymerase Chain Reaction (PCR) Conditions of HmuT R237A

Cycle

Temperature

Time

Number of Cycles

Hot Start

95 °C

2 min

1

Melting

95 °C

30 sec

Annealing

72 °C

1 min

Extension

68 °C

10 min

Final Extension

68 °C

10 min

1

Hold

4 °C

overnight

1
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2.4.3 Agarose Gel
A gel was run to ensure proper formation of desired plasmid. A 1% (w/v) agarose
powder (0.5 g), nanopure water (49 mL), and TAE 50 x buffer (1 mL) were added to a Pyrex
bottle. To form the gel, the mixture was placed in a water bath and boiled until fully dissolved.
The solution was cooled (~ 5 min) and the contents were poured into gel cast to solidify. The
samples containing each reaction were arranged. The PCR samples (10 µL) were mixed with
DNA 6x loading dye (2 µL) from Thermo Fisher Scientific. The solidified gel was immersed in
a running buffer containing, nanopure water (980 mL) and TAE 50x buffer (20 mL). Each
sample was loaded into an individual well (12 µL) and run at 70 V for 70 min. The gel was
imaged using the Benchtop 3UV Transilluminator Imaging System.
2.4.4 DpnI Digestion
Reaction 3 (see Table 2.3) was digested using FastDigest DpnI from Thermo Fisher
Scientific. A solution containing reaction 3 (38 µL), DpnI buffer (5 µL), nanopure water (6 µL)
and DpnI (1 µL) was prepared. The solution was held at 37 °C for 1 h using the PCR Eppendorf
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Mastercycler gradient instrument. An additional microliter of DpnI enzyme was added to ensure
the digestion of all methylated DNA. The reaction mixture was held at 37 °C for an additional
hour. The sample was stored overnight at 20 °C.
2.4.5 Agar Plate Preparation
Agar plates were prepared (4) to proceed with transformation of plasmid to competent
cells. Luria-Bertani (LB) medium (2 x 50 mL) containing tryptone (0.5 g), sodium chloride (0.5
g), yeast extract (0.25 g), and agarose (0.75 g) was prepared. The medium was autoclaved (20
min cycle). Both solutions were left to slightly cool (~ 5 min) and 25 µL of a 100 mg/mL stock
solution of kanamycin was added (final 50 μg/mL) to one medium for the transformation step.
In sterile environment, the contents of each flask were poured into two plates and left to solidify.
The plates were then stored in refrigerator (4 °C).
2.4.6 Calcium Chloride Solution Preparation
A 100 mM calcium chloride solution was prepared (100 mL). A solution containing 75
mM calcium chloride dihydrate (1.1 g), 15% glycerol (15 mL), 10 mM PIPES (0.3 g), and 5 mM
magnesium chloride hexahydrate (0.1 g) was added to a beaker. Nanopure water was added (90
mL) and the pH was adjusted to 7.0 using 3 M sodium hydroxide. Nanopure water was used to
adjust the volume to 100 mL.
2.4.7 Cell Transformation
An E. coli BL21 cell line was used in this experiment to later express the protein. The
cells were grown overnight in LB media (10 mL). The cells grown overnight (2 mL), were left
to grow in a large scale medium (100 mL) at 225 rpm and 37 °C. The flask was placed on ice
once an OD of 0.6 was reached. The contents of the flask were equally fractioned out into two
falcon tubes and spun at 4,580 rpm for 10 min at 4 °C. The supernatant was discarded and
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calcium chloride solution (20 mL) was added. The pellet was resuspended and then left to sit for
10 min. The solution was spun at 4,580 rpm for 10 min at 4 °C. The supernatant was drained
and calcium chloride (4 mL) was added. The digested PCR reaction 3 solution (1 µL) and now
competent cells (50 µL) was incubated in a microcentrifuge tube on ice for 20 min. The solution
was heat shocked in a water bath at 4 °C for 45 sec, then immediately placed back on ice for 2
min. The solution (51 µL) was then added to warm LB media (250 µL) and shook at 37 °C for 1
h. The sample was streaked on two agar plates with kanamycin and left to grow overnight at 37
°C. One colony was chosen and half was grown in LB media (10 mL) for DNA extraction. The
other half of the same colony was used to streak a new agar plate with kanamycin.
2.4.8 HmuT R237A Protein Expression
LB media was prepared by adding 10 g of tryptone, 10 g of sodium chloride, 5 g of yeast
extract and 1,000 mL of Barnstead Diamond Nanopure water into four 2 L flasks. All media was
sterilized for a 20 min cycle, using a Steris Amsco Renaissance autoclave. After cooling for 3-4
h to room temperature, 500 µL of 100 mM kanamycin was added to each 2 L flask. To separate
125 mL flasks, 25 mL of the broth containing kanamycin was added and inoculated with a
R237A glycerol stock solution, using the sterile flame loop technique. All flasks were incubated
in a New Brunswick Scientific Excella E24 incubator shaker, at 37 °C on 220 rpm for
approximately 16 h. The contents were then returned to the 2 L flasks containing the remaining
LB and kanamycin, to allow for growth on a larger scale. Using a Varian 50 Bio UV-visible
spectrophotometer, the optical density (OD) readings at 600 nm were taken as a function of time.
Once the absorbance reached an OD600 between 0.6 and 0.8 (approximately 3 h), the media was
induced with 1 mL of 100 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The temperature
was reduced to 27 °C and the media continued shaking for another 3 h. The cells were harvested

14

using a JLA 8.100 in a rotor Beckman Coulter Avanti-T26 XPI centrifuge at 8,000 g for 30 min
at 4 °C. The cell pellets were stored at 80 °C.
2.4.9 HmuT R237A Protein Purification
The R237A cell pellets were placed in a beaker, on ice, containing 174 mL buffer A (100
mM Tris-Cl, 150 mM NaCl, pH 8.0), 20 mL of 100 mM magnesium chloride, 2 mL of 10 mM
phenylmethylsulfonyl fluoride (PMSF), 4.0 mL of 10 mg/mL lysozyme, and 5 µg/mL each of
DNase I Recombinant (Lot 14636800) and RNase A (Lot 70297724) (Roche Diagnostics) from
bovine pancreas. After the mixture had been homogenized, the sample was lysed on ice for 20
min using a Fisher Scientific Sonic Dismembrator Model 500 Sonicator. The settings of the
experiment was 20 sec pulse on time and 5 sec pulse off time with an amplitude of 15%. Once
lysed, the samples were centrifuged using an Eppendorf Centrifuge 5804R 15 amp Version at
6,500 rpm at 4 °C for 30 min. The supernatant was collected and the pellets discarded.
The following purification steps were conducted at 4 °C using a GE Healthcare ÄKTA
fast protein liquid chromatography (FPLC, Amersham BioSciences); all buffer solutions were
adjusted to pH 8.0. The sample (~ 50 mL) was loaded onto a Strep-Tactin Superflow column (5
mL, IBA BioTAGnology) equilibrated with buffer A (100 mM Tris-HCl, 150 mM NaCl, pH
8.0). Unbound material was washed out with 5 column volumes (CV) of buffer A. The mutant
was eluted with 10 CV of buffer B containing 100 mM Tris-HCl, 150 mM NaCl, 2.5 mM
desthiobiotin applied via a linear gradient.

2.5

Results and Discussion
The results from the agarose gel of reaction three produced the desired product (Figure

2.3). After expressing R237A, it was purified. The chromatogram shows that pure protein was
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obtained (Figure 2.4). This sample further was run on SDS gel and pure fractions were collected
and stored. In the batch of protein expressed, 3.2 mg/mL (5 mL) was obtained.

Figure 2.3 UV-visible imaged agarose gel of PCR reactions for HmuT R237A. From left:
lanes 1, 2, 3 and 4 correspond to reactions 1, 2, 3 and 4, respectively, from Table 2.3.

Figure 2.4 Chromatogram of Strep-Tag R237A shows the isolated protein.
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In general, to calculate heme binding, the extinction coefficient of the heme in a heme
protein is used (1 x 105 M-1 cm-1 at the Soret). The ratio of the absorbance of the Soret: 280 can
give a rough estimate of the heme loading of the protein. As isolated, WT CdHmuT is ~80%
heme loaded, whereas the as-isolated R237A mutant is only ~ 40% heme loaded. The reduction
in heme loading of the mutant in comparison to the WT protein may indicate that Arg237 plays a
role in maintaining heme integrity. Figure 2.5 shows an overlay of the two UV-visible
absorption spectra, normalized to 1.0 at the Soret (~ 400 nm).

Figure 2.5 Overlay of the UV-visible absorption spectra of HmuT WT and mutant R237A,
both in 50 mM Tris-Cl buffer at pH 7.0. The spectra were normalized to 1.0 at the Soret. The
insert shows the magnified α,β region.

There is very little spectral difference between the WT and R237A, indicating that
Arg237 may be in or near the heme pocket, but is not directly interacting with the heme. This is
consistent with the C. glutamicum structure of HmuT which shows that arginine is a hydrogen
bonding partner to the axial tyrosine 45. It would be expected that the UV-visible absorbance
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spectrum of R237A would change dramatically if the arginine residue had a direct interaction
with the heme. For example, the UV-visible absorption spectra of the HmuT heme with mutated
axial ligands (H136A and Y235A) vary in both the position of the Soret band and the number of
bands in the α,β-region 41. Although this residue was not directly observed as a heme ligand,
Arg237 is conserved across multiple species of Corynebacterium and was therefore studied in
more detail.

Figure 2.6 Thermal folding of WT HmuT. Measuring fraction folded as a function of
temperature ( °C). WT (blue filled triangle), H136A (green filled square), Y235A (red open
diamond), R237A (cyan open square), Y272A (orange filled circle), M292A (magenta open
triangle), Y349A (purple open circle), and Y349F (grey filled diamond). Samples were in 50 mM
potassium phosphate, pH 7.0 Taken from 41.

WT HmuT gave a Tm of 66.8 °C while R237A gave a Tm of 54.0 °C. This supports the idea that
the axial tyrosine needs Arg237 to maintain the integrity of the heme in the pocket as the Tm of
this mutant is reduced by ~13 °C as compared to the WT.
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Resonance Raman spectroscopy was also used to help support the argument that Arg237
is the hydrogen bonding partner to the axial tyrosine. A back-bonding correlation, in which the
frequency of the Fe-CO bond stretch is plotted against the frequency of the Fe-CO bond stretch
for the ferrous carbonyls of HmuT is shown in Figure 2.7 41. Oxygen-based heme ligands appear
in the lowest energy quadrant of the graph. With the addition of the HmuT examples to the plot,
and particularly with the addition of R237A, it became clear that the classical single linear
correlation could be divided into two. Previous studies done on nitric oxide synthase complexes
showed that a strong hydrogen-bond donation could weaken the strength of the proximal ligand
41

. This led to an investigation of the hydrogen bonding partners of the proteins on the plot. A

detailed study of the x-ray structures of known proteins indicated that the upper line involves
hydrogen bonding to arginine (two hydrogen bonds), while the lower line involves a single
hydrogen bond.
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Figure 2.7 Backbonding correlation plot of νFe–CO versus νC–O for ferrous carbonyls
of heme proteins As-isolated WT (blue), H136A (green), and Y235A (red) are shown as open
stars while M292A (magenta), and R237A (cyan) are shown as solid stars on the plot. Catalase,
blue hexagon [60]; HasA, open circle; CCP, open square; HRP, filled triangle; P450, open
triangle; globins, filled square; p22HBP, open diamond; HO-1(H25Y), blue upside down
triangle and BSA, blue sideways tri- angle. The dashed grey line is the least-squares line for sixcoordinate Fe–CO adducts in which the proximal ligand is thiolate or imidazolate; the dotted
grey line is the least-squares line for Fe–CO adducts with proximal His (neutral imidazole). The
solid blue line represents tyrosine-ligated heme proteins with the guanidinium group of Arg
available for hydrogen bonding to the Tyr and the dashed blue line which the ligand trans to CO
is coordinated through a neutral oxygen atom. Taken from 41.

The guanidinium group of arginine, with a bifurcated hydrogen bond, weakens the Fe-CO bond,
therefore shifting the correlation line up as shown in Figure 2.7 41. There are a handful of
crystallized proteins that employ Try-Arg hydrogen-bonding (Table 2.1) 41, all of which are in
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position to have similar distances to the axial tyrosine. The Raman data are in accord with the
hypothesis that R237 is in position to be the hydrogen bonding partner to Y235 of HmuT.
Our work has shown that not only the axial ligands of heme proteins are required for
heme binding, but also other residues in the pocket. In particular, R237 serves as the hydrogenbonding partner to the axial Y235. Removal of this residue gives a similar UV-visible
absorbance profile, yet the heme binding capacity of the protein is reduced by 50%. Thermal
melting studies of this R237A mutant, compared to the WT, showed the overall stability of the
protein was reduced upon removal of this residue. The resonance Raman spectra are consistent
with serving as a hydrogen bonding partner to Y235. Overall, these studies add to the growing
number of identified hydrogen bonding heme protein motifs and reiterate that multiple residues
contribute to the ability of efficient heme binding in these proteins.

3

CHAPTER 3: THE SECOND NEAT DOMAIN SHR IN STREPTOCCOCUS
PYOGENES

3.1

Streptococcus pyogenes and Heme Uptake
Streptococcus pyogenes is a gram-positive pathogenic bacterium belonging to group A β-

hemolytic streptococcus (GAS) bacteria 12, 46-48. β-hemolytic bacteria break down red blood
cells. These bacteria are responsible for a wide range of infections and diseases including
streptococcal pharyngitis, acute pharyngitis, rheumatic heart disease, impetigo, and cellulitis.
GAS obtains required iron need as a nutritional source from heme 49. Heme sources include
hemoglobin, the hemoglobin:haptoglobin complex, heme albumin, myoglobin, and catalase.
Heme is first transferred to the streptococcal hemoprotein receptor (Shr), a large
membrane-anchored protein. Shr has a hydrophobic tail that is positively charged associating it
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with the cytoplasmic membrane 49. This cell-surface protein contains two NEAT domains, ShrNEAT1 (Shr-N1) and Shr-NEAT2 (Shr-N2). Shr-N1 is preceded in the sequence by a distinctive
N-terminal domains (NTD); Shr lacks the cell-wall anchoring motif that is found in Isd receptor
proteins of S. aureus 49. Shr-N1 obtains heme from the extracellular space and is able to transfer
to either Shr-N2 or directly to Shp (streptococcal cell surface protein) 49. Heme is then
transferred to the ABC heme transporter encoded by the sia (streptococcal iron acquisition) gene
cluster 12, also known as the hts (heme transport S. pyogenes) gene cluster 50. And is shuttled
into the cell as depicted in Figure 3.1.

Figure 3.1 Heme uptake system in Streptococcus pyogenes.

3.2

NEAT Domains
The S. pyogenes heme uptake pathway utilizes two near iron transport (NEAT) domains

during heme transfer. NEAT domains consist of conserved secondary structural features
including β-strands and a 310 α-helix 51. The classical NEAT heme-binding motif involves an
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YXXXY motif in which the first Tyr from the β-8 strand is an axial ligand and the second
tyrosine is a hydrogen-bonding partner to the first 52. An example of a typical NEAT domain
structure is shown in Figure 3.2.

Figure 3.2 Crystal structure of IsdX2 NEAT-5 domain from Bacillus. anthracis.

In recent years, variations on this theme have been discovered. S. aureus IsdB-N2 has a
Met/Tyr axial ligand set 53. IsdA binds tyrosine in the ferric state and histidine in the ferrous
state 54. Bacillus anthracis HalA utilizes a YXXXF motif, rather than YXXXY 55. The proposed
hemophore Hbp2 (Hbp2-N2) from Listeria monocytogenes differs in that the axial tyrosine
extends from the β-7 strand, rather than the β-8 strand 56. This emerging variety among heme
axial ligand motifs of NEAT proteins may imply the ability of these proteins to play roles other
than binding and transferring heme to the next protein in the pathway.
3.3

Autoreduction of Iron Shr-N2
Shr-N1 is predicted to utilize a bis-methionine axial ligation set to coordinate the heme

iron, as indicated by sequence alignment, homology modeling, and various spectroscopic
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analyses. Sequence alignment of Shr-N1 with Shr-N2 indicated that Shr-N2 to also uses a bismethionine axial ligand set with an M26 N-terminal ligand and an M136 C-terminal ligand. ShrN2 is isolated as a mixture of the Fe(II) and Fe(III) forms of the protein. This is not surprising as
heme proteins with methionine ligands typically have higher reduction potentials, making it
easier to change oxidation states. Interestingly, Shr-N2 is prone to autoreduction of the heme,
unlike the sister domain Shr-N1 which does not autoreduce, although it proposed to have the
same axial ligands as Shr-N2. The Shr-N2 heme autoreduces as the pH increases and
autoxidizes as the pH decreases; the process occurs in about two hours. The most likely cause of
autoreduction could be attributed to nearby lysine residues. A proposed scheme of this process is
shown in Figure 3.3. The facile change in oxidation states may be physiologically significant.
Figure 3.4 shows the homology model of Shr-N2 and those proposed lysine responsible for
autoreduction. Heme transfer studies between Shr-N1 and Shr-N2 was shown to be reversible
and may indicate Shr-N2 is used as a storage source of heme 49. Based on these findings, it
could be the case that in environments with high levels of iron, Shr-N2 could store the heme until
the iron levels become too low, in which the heme could be passed back to Shr-N1 and re-enter
the pathway.

Figure 3.3 Proposed autoreduction scheme of Shr-N2.
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Figure 3.4 Homology model of Shr-N2 showing axial ligands M26 and M136; potential
electron donors K29 and K57.

3.4

Low Spin State Ligands
Low-spin state ligands forcibly pair electrons within the 3d orbital resulting in the

formation of octahedral complexes. Amino acid resides such as histidine, methionine, cysteine
and lysine have ligand field strengths which generate this low spin state. These bis-coordinate
heme centers often undergo electron transfer reactions due to the redox change at the metal ion.
Studies of low-spin cytochromes show bis-histidine and methionine/histidine coordination are
the most common ligation combinations. However, lysine/histidine has been observed in
mitochondrial cytochrome c 57, and bis-methionine ligation in bacterioferritin 58-61. Therefore, it
could be the case that Shr-N2 K29 and K57 are nearby the proposed heme methionine ligands in
order to carry out the electron transfer reactions required for heme storage or other protein
functions.
3.5

The Long-Wavelength Charge-Transfer Fe-S Band
It has long been known that the Fe-S bond in heme gives rise to a long wavelength charge

transfer band. Perhaps the best-known example is cytochrome c, in which the bond occurs at
695 nm. Table 3.1 gives a compilation of known methionine-ligated proteins; charge-transfer
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transitions tend to be sensitive to the oxidation state on the central iron. It is observed that the
charge transfer band primarily arises when the iron is under an oxidized high-spin state. The
approximate wavelengths however, vary greatly between 600 nm – 695 nm.
Table 3.1 Charge transfer bands of bis-methionine proteins

Class
Met/His

Met/Met

Met/Tyr

3.6

Protein
Cytochrome c
IsdE
SiaA
Bacterioferritin
Shp
H102M cytochrome b562
Shr NEAT1
Shr NEAT2

λ nm charge transfer
695
650
734
610
~ 645
~ 640

~ ɛ (M-1 · cm-1)
830
5.00 x 104
1.25 x 103
7.4 x 10-3
-

IsdB-N2

630

2.0 x 104

Reference
62
63
64
60
65
66

This work
This work
53

Axial Methionine Fluxionality
It is postulated that there is a low intrinsic affinity of thioether for ferric heme 67. The

most common example would be cytochrome c where it is seen that donor ligands have the
ability to frequently replace the axial methionine under an oxidative state. The mobility of the
iron-thioether bond is proposed to be important to the function of these proteins. This mobility is
attributed to conformational changes in heme axial methionine seen by hyperfine shifts in NMR
spectra 68. It is suggested that the sulfur bond of the methionine side chain becomes inverted.
These orientations contribute to the fluxionality of the axial methionine caused by this heme
pocket strain.
3.6.1 Spectra Mono/Bis Methionine
Spectroscopic studies of of mono and bis-methionine ligation proteins are limited to the
few known examples of these systems. With the addition of low concentrations of
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tetrahydrothiophene (THT) to exogenous ligand-free ferric H93G Mb, spectral changes were
observed consistent with what would be observed for a mono-methionine ligated protein 69. In
particular, a red shift of the Soret maximum and an intensity increase of the charge transfer band
at approximately 600 nm were seen 69. The ligand trans to the axial methionine was thought to
be a hydroxide group. At high concentrations of THT and at high pH, bis-THT H39G Mb could
be observed via MCD. In comparison with the mono-THT, the Soret was more red shifted and
the intensity of the α,β bands increased. However, the charge transfer band around 600 nm
decreased 69. Similar studies were performed on Shr-N2 by Dan Collins and John Dawson. The
MCD at pH 6.5 of Shr-N2 is similar to that of bis-THT. At pH 10, the MCD is consistent with
mono-THT, as shown in Figure 3.5.

Figure 3.5 MCD of Shr-N2. Performed by Dan Collins and John Dawson
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3.7

Materials and Methods

3.7.1 DNA Extraction WT Shr-N2.
DNA extraction was performed using the QIAprep Spin Miniprep Kit (50) from the
company QIAGEN. A series of buffers and centrifugation techniques were used to extract the
DNA from the plasmid by following the kit manual provided.
3.7.2 Shr-N2 K29A and K57A Mutations
The Shr-N2 WT clone was a gift from Dr. Zehava Eichenbaum. The sequence of Shr-N2
was re-verified. Residues K29 and K57 were mutated to A29 and A57 (Table 3.2-3.3)
respectively via PCR reactions shown in Table 3.4.
Table 3.2Experimental Primer Design for Shr-N2 K29A

Oligo
Name

MW

Shr-N2
K29A
Forward

9951

Shr-N2
K29A
Reverse

10014

Dimer

Secondary
Structure

GC%

DNA Sequence

72.6

No

Moderate

46.8

GGTATAAAGGTTGGTGCGATGTTAGGCTACCT

73.0

No

Moderate

45.4

AAGGTAGCCTAACATCGCACCAACCTTTATACC

Tm
°C

Table 3.3 Experimental Primer Deisgn for Shr-N2 K57A

Oligo
Name

MW

Shr-N2
K29A
Forward

9951

Shr-N2
K29A

10014

Dimer

Secondary
Structure

GC%

DNA Sequence

72.6

No

Moderate

46.8

GGTATAAAGGTTGGTGCGATGTTAGGCTACCT

73.0

No

Moderate

45.4

AAGGTAGCCTAACATCGCACCAACCTTTATACC

Tm
°C
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Reverse

Primer designs were checked in the Sigma Oligo program; this company provided the primers.
Multiple reactions conditions were run for PCR. A variation in the DMSO concentration (2%
and 5%) and the amount of plasmid used varied in the reactions as shown in Table SP16 F. PCR
was performed on the listed reactions using the touchdown method.

Table 3.4 Touchdown Polymerase Chain Reaction Conditions for K29A and K57A

Cycles

Temperature

Time

Number of Cycles

Hot Start

95 °C

2 min

1

Melting

95 °C

30 sec

Annealing

63 °C-72 °C

1 min

Extension

68 °C-72 °C

10 min

Final Extension

68 °C-72 °C

10 min

1

Hold

4 °C

overnight

1

20

This included 25 cycles of melting, annealing and extending. After the cycles were completed,
the reactions were held at 4 °C overnight.
3.7.3 Agarose Gel
A gel was run to ensure proper formation of desired plasmid. A 1% (w/v) agarose
powder (0.5 g), nanopure water (49 mL), and TAE 50 x buffer (1 mL), previously prepared, were
added to a Pyrex bottle. To form the gel, the mixture was placed in a water bath and heated until
fully dissolved. The solution was cooled (~ 5 min) and the contents were poured into gel cast to
solidify. The samples containing each reaction was then prepared. The PCR samples (10 µL
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each) were mixed with DNA 6x loading dye (2 µL each). A ladder solution was prepared using
nanopure water (4 µL), 6x loading dye (1 µL), and 1 kb DNA Ladder (1 µL) provided by New
England BioLabs Inc. The solidified gel was immersed in a running buffer containing, nanopure
water (980 mL) and TAE 50x buffer (20 mL). Each sample was loaded into each individual well
(12 µL) and run at 70 V for 70 min. The gel was imaged using the Benchtop 3UV
Transilluminator Imaging System.
3.7.4 Dpn1 Digestion
Reaction 1 was digested using DpnI. A solution containing reaction 1 (38 µL), DpnI
buffer (5 µL), nanopure water (6 µL) and DpnI (1 µL) was prepared. The Thermocycler was
used to digest reaction 1. The solution was held at 37 °C for 1 h. Another 1 µL aliquot of DpnI
enzyme was added to ensure the digestion of all methylated DNA and was held at 37 °C for an
additional hour. The sample was stored overnight at 20 °C.
3.7.5 Transformation
E. coli BL21 DE3 (New England BioLabs) cell line was used in this experiment to
transform the mutated plasmid. Reaction 3 solution (1 µL) and competent cells (50 µL) was
incubated in a microcentrifuge tube on ice for 20 min. The solution was heat shocked in a water
bath at 4 °C for 45 sec, then immediately placed back on ice for 2 min. The solution (51 µL) was
added to warm LB media (250 µL) and left to shake at 37 °C for 1 h. The sample was streaked
on two agar plates with kanamycin and incubated overnight at 37 °C. One colony was chosen
and half was grown in LB media (10 mL) for DNA extraction. The other half of the same colony
was used to streak a new agar plate. The DNA extracted was sequenced at GENEWIZ.
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3.7.6 Shr-N2 Protein Expression
LB media was prepared by adding 10 g of tryptone, 10 g of NaCl, 5 g of yeast extract
and 1 L of nanopure water from Barnstead Diamond into four 2 L flasks. All media was
sterilized for 20 min, using a Steris Amsco Renaissance autoclave. After cooling for 3-4 h to
room temperature, 500 µL of 100 mM kanamycin was added to each 2 L flask. To separate 125
mL flasks, 25 mL of the broth containing kanamycin was extracted and inoculated with the stock
solution previously made, using the sterile flame loop technique. All flasks were incubated in a
shaker, at 37 °C on 220 revolutions per minute (rpm) for approximately 16 h. The contents were
then returned to the 2 L flasks containing the remaining LB and kanamycin, to allow for growth
on a larger scale. Optical density readings at 600 nm were taken as a function of time. Once the
absorbance reached an OD between 0.5 and 0.7 (approximately 3 h), the media was induced with
1 mL of 100 mM isopropyl β-D-1-thiogalactopyranoside. The temperature was reduced to 27 °C
and the media continued shaking for another 3 h. The cells were harvested and centrifuged at
8,000 G for 30 min at 4 °C. The cell pellets were stored in the 1 L centrifuge tubes at 80 °C.
3.7.7 Shr-N2 Protein Purification
The Shr-N2 cell pellet was homogenized, on ice, in a solution containing buffer A (100
mM Tris-Cl, 150 mM NaCl, pH 8.0), 100 mM magnesium chloride, 10 mM
phenylmethylsulfonyl fluoride, 10 mg/mL lysozyme, 5 µg/mL each of DNase I Recombinant
(Lot 14636800), and RNase A (Lot 70297724) from Roche Diganostics. The solution was lysed
for 30 min (10 sec pulse on time and 10 sec pulse off time, amplitude of 15%). Once lysed, the
samples were centrifuged at 7,000 rpm at 4 °C for 45 min. The supernatant was collected and
stored.
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The following purification steps were conducted at room temperature and all buffer
solutions were adjusted to pH 8.0. The sample (40 mL) was loaded onto a Strep-Tactin
Superflow column (5 mL, IBA BioTAGnology) equilibrated with buffer A (100 mM Tris-HCl,
150 mM NaCl, pH 8.0). Unbound material was washed out with 5 column volumes (CV) of
buffer A. The mutant was eluted with 10 CV of buffer B containing 100 mM Tris-HCl, 150 mM
NaCl, 2.5 mM desthiobiotin, pH 8.0 applied via a linear gradient. This sample was stored in the
-80 °C freezer Roughly 2.3 mg/mL was purified from each expression batch.
3.7.8 pH Titration- autoxidation and autoreduction of WT Shr-N2
The spectra of Shr-N2 WT were measured as a function of pH. The first experiments
were run previously by Yu Cao. In the first titration experiment, WT Shr-N2 in 20 mM each
CAPS, MES, and Tris-Cl was taken to pH 10.5 with 1 M NaOH. This sample was followed by
UV-visible spectroscopy every 10 min for the first 2 h and every 30 min for the next 17 h. The
pH of this sample was then adjusted to 6.1 using 1 M HCl and UV-visible absorption spectra
taken every 10 min for 24 h. The pH was then adjusted to 10.5 using 1 M NaOH and UV-visible
absorption spectra were taken every 10 min for 24 h. In the second titration experiment, the
buffer was exchanged to 20 mM each CAPS, MES, and Tris-Cl at pH 6.5 and the sample was
held at this pH for 2 h until ASoret was less than 0.001 over 10 min. The sample was then taken
to pH 10.1 and the spectrum recorded every 10 min for 24 h.
The experiment was rerun on a second batch of protein. The samples were prepared in
20 mM each CAPS, MES, and Tris-Cl. The pH was taken to 6.1 with 1 M HCl; UV-visible
absorption spectra were taken every 10 min for 24 h. In the second experiment, the pH of this
sample was adjusted to 10.5 using 1 M NaOH and, again, UV-visible absorption spectra were
taken every 10 min for 24 h. Rate constants for both trials were determined and compared.
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3.7.9 pH Titration- autoxidation and autoreduction of WT Shr-N2
A sample of WT Shr-N2 was prepared in 10 mM Tris-Cl and 1mM EDTA pH 8.0 (TE
buffer). Each sample was first adjusted to pH 6.1 using 1 M HCl. The spectra was followed
every 10 min for 24 h. The pH was then adjusted to 10.5 and their spectra were followed every
min for the first 2 h and every ten minutes for the remaining 22 h. Data were fit to an equation
involving two first-order processes using KaleidaGraph fitting program.
A = A0e(-kt)+A1e(-kt)+b

3.8

Results and Discussion
The results were positive for the mutations of Shr-N2. The gel from PCR experiment was

imaged using the Benchtop 3UV Transilluminator Imaging System, as shown in Figure 3.7. All
lanes showed the desired product, so reaction 1 was used for digestion. GENEWIZ was used to
confirm the correct mutations were obtained.

Figure 3.6 UV- visible imaged agarose gel of PCR reactions Shr-N2 K29A, K57A,
respectively.
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NEAT2 is isolated as a mixture of the oxidized and reduced forms. An overlay of ShrN2 and the mutants show the differences in spectra as-isolated shown in Figure 3.7. Each batch
of protein expressed varies to the percent of reduction after purification as depicted in Figure 3.7.

Figure 3.7 Overlay of Shr-NEAT2 WT and mutants as-isolated.

3.8.1 pH Dependent Autoxidation of WT Shr-N2
For experiments run by Yu Cao of WT Shr-N2, a sample was run at pH 6.6, over 24 h. It
showed a large variation in the rate constants as a function of pH shown in Figure 3.12. Data at
410 nm were not well-fit by either one or two exponentials (Figures 3.8). The rate constants
range from 0.8 – 2 h-1, again about 10 – 20 times that of the second rate constant (Table 3.5).
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Table 3.5 Autoxidation rate constants of WT Shr-N2

To compare the reproducibility of the protein, a sample of WT Shr-N2 initially at pH 8
(largely reduced, 88%), 1 M HCl was added to take the solution to pH 6.6. Over 24 h, the Soret
peak at 410 nm (oxidized) increased and the peak at 428 nm (reduced) decreased In the α,β
region, both peaks at 532 nm and 560 nm also decrease over time, indicating the oxidation of the
protein (Figures 3.13). A rather clean transition is observed, as seen in the difference spectra.
Signs of an isosbestic point can be seen at ~ 430 nm (Figure 3.14). Data at 410 and 532 nm were
not well-fit by either one or two exponentials (Figures 3.9 and 3.11). Overall, the first process
had a rate constant ranging from 0.6 – 0.7 h-1, about 10 – 20 times that of the second rate
constant. Comparisons of the autoxidation of both experiments are shown in Table 3.5.Based on
the comparison from both experiments, it was concluded that autoxidation of Shr-N2 is
irreproducible.
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Figure 3.8 Timescale of ST Shr-N2. Data fit at 410 nm.

Figure 3.9 Timescale of ST Shr-N2. Data fit at 428 nm
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Figure 3.10 Timescale of ST Shr-N2. Data fit at 532 nm

Figure 3.11 Timescale of ST Shr-N2. Data fit at 560 nm
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Figure 3.12 YC_VI_7. Absorbance vs. wavelength over 24 h for a solution of WT ShrN2
in 20 mM CAPS, MES, and Tris-Cl at pH 6.6. The pH of the sample was adjusted from 10.4 to
6.6 using 1 M HCl. The absorbance at 428 nm decreases while that at 410 nm increases. The
α,β bands decrease. Data recorded by Yu Cao.
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Figure 3.13 Autoxidation of WT Shr-N2 pH 6.1. Sample prepared in TE buffer (10 mM
Tris-Cl, 1 mM EDTA pH 8.0). 1 M HCl added to take pH down to 6.1. Spectra followed every
10 min for 24 h. Arrows indicate the increasing and decreasing peaks over time.

Figure 3.14 Difference spectra for autoxidation of WT Shr-N2 at pH 6.1.
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3.8.2 pH Dependent Autoreduction of WT Shr-N2
Yu Cao’s sample described above was then adjusted to pH 10.5 with 1.0 M NaOH and
followed for 24 h. The protein reduced in a process largely complete in about 2 h. The same
then began to autoxidize again, a process that was not complete in 24 h (Figure 3.15). Fitting to
a biphasic process was not successful. Overall, changes as a function of pH were only partially
reversible, with significantly less protein available to reduce after a reduction-oxidation cycle
(Figures 3.8-3.11). As seen in Yu Cao’s data, at high pH after a 24 h span, the proteins spectra is
consistent with precipitation or denaturation. Data at pH 10.5 could not be fit.

Figure 3.15 . Absorbance vs. wavelength over 18 h for a solution of WT ShrN2 in 20 mM
CAPS, MES, and Tris-Cl at pH 10.4. The pH of the sample was adjusted to 10.4 using 1 M
NaOH. The absorbance at 428 nm increases while that at 406 nm decreases. The α,β bands
decrease. Data recorded by Yu Cao.
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The new sample of protein from the same stock solutions was prepared for WT Shr. The
pH of the sample was adjusted to 10.5 and spectra were taken over time. Figure 3.16 shows the
spectra over time along with the difference spectra in Figure 3.17. The lack of isosbestic points
leads to conclude that more than one intermediate is present in solution. The absorbance of WT
both increased and decreased over time. Rate constant fittings at those wavelengths have a
greater margin of error as a result. Only the reductive branch of the data set could be fit in
KaleidaGraph to obtain approximate rate constants for WT Shr. Data not shown.

Figure 3.16 Autoreduction of WT Shr-N2 at pH 10.5. Sample prepared in TE buffer (10
mM Tris-Cl, 1 mM EDTA pH 8.0). To the sample, 1 M NaOH was added to take pH up to 10.5.
Spectra followed every minute for 2 h then every 10 min for 22 h.
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Figure 3.17 Difference spectra for autoreduction of WT Shr-N2 at pH 10.5.

There are two possibilities that may be contributing to this occurrence. If lysine is involved
in autoreduction, each cycle probably destroys the lysines involved. Therefore, an
“autoreduced” sample may already have “lost” at least one lysine. Another possibility is that the
methionine residue can have two orientations with respect to the heme, essentially “R” and “S”
conformations. Therefore, a bis-methionine protein can have four different conformational
states. These orientation possibilities have been studied for some of the cytochrome c 68. Based
on the data shown, there is no consistency among the rate constants and in comparison at low ans
high pH. In solution there are multiple processes occurring giving rise to unstable behavior.
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4

CHAPTER 3: THE DNA TRANSCRIPTION REGULATOR PEFR IN
STREPTOCOCCUS PYOGENES

4.1

Multiple antibiotic resistance regulators and porphyrin-regulated efflux via PefR
Streptococcus pyogenes causes many human diseases including strep throat, pharyngitis

(rheumatic fever), toxic shock syndrome, necrotizing fasciitis, and joint or bone infections.
Antibiotic resistance is a growing concern 70-72. Because this organism uses hemin as an iron
source, 73, control of proteins that bind and transport heme is of interest. Recently, the
Eichenbaum laboratory performed microarray analysis of the transcription response to heme
exposure in the Group A Streptococcus (GAS) genome 48. The porphyrin regulated efflux (pef)
regulon consists of gene clusters pefAB and pefRCD that code for transporter proteins (pefAB,
pefCD) 74. In particular, a porphyrin-regulated efflux protein PefR was discovered. PefR
controls the expression of these iron-regulated proteins. PefR has a molecular mass of 17.4 kD
with a theoretical pI of 9.2. In GAS it is thought that increased levels of heme or PPIX activates
transcription by releasing PefR from its promoter region upon heme or PPIX binding 48.
The structure of PefR, based on homology modeling, belongs to the family of Multiple
antibiotic resistance regulators (MarR) proteins. MarR are negative regulators encoded by the
marRAB locus in E. coli. This regulation family controls the expression of proteins resulting in
resistance to conventional antibiotics 75. Roughly 100 MarR-like proteins have been
characterized to date, in which many bind to their individually associated DNA. Structurally,
MarR proteins are found as dimers. They are α-helix-rich; the N- and C- termini form a dimer
domain that is stabilized by hydrophobic interactions. MarR proteins have a helix-turn-helix
motif, common in DNA binding. It is composed of two helices joined by a short strand. The
first helix is the recognition helix. The second helix is known to be the stabilizing helix which
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interacts with the DNA itself and therefore stabilizes helix one via hydrophobic interactions.
Results from the Protein Data Bank show many topologically similar proteins from different
organisms such as P. aeruginosa, B. subtilis and E. faecalis. Although the family has low
sequence identity (~ 20%), most of the structures are very similar in three dimensions. MarRlike proteins bind to lipophilic compounds. MarR proteins bind to DNA in the apo form and are
released from the DNA in the holo form. Following the general pattern of MarR proteins, PefR
is thought to exist as a dimer which releases itself from the promoter region upon binding heme.
This release leads to the repression of the two heme export systems pefRCD and pefAB.
The goal of the current study was to determine the axial ligand(s) bound to the hemin in
the holo form of the protein, verify the stoichiometry of hemin binding, and create pure protein
for future DNA binding studies. The previous construct of PefR used a histidine tag 48. Because
the histidine tag can bind hemin, 76, 77, we have used a Strep-tag in our work.
4.2

Materials and Methods

4.2.1 WT PefR Protein Transformation
All water was 18 mΩ from a Barnstead water purifier. E. coli BL21 DE3 (New England
BioLabs) cell line was used to transform WT PefR plasmid, designed by Rizvan Uluisik and
prepared by Novagen. The plasmid (1 µL) and competent cells (50 µL) were incubated in a
microcentrifuge tube on ice for 20 min. The solution was heat shocked in a water bath at 42 °C
for 45 sec, then immediately placed back on ice for 2 min. The solution (51 µL) was added to
warm LB media (250 µL) and left to shake at 37 °C for 1 h. The sample was then streaked onto
agar plates with kanamycin (50 μg/mL) and incubated overnight at 37 °C. One colony was
chosen and half was grown in LB media (10 mL) for DNA extraction. The other half of the
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same colony was used to streak a new plate. Once the DNA was extracted, it was sent to be
sequenced at GENEWIZ.
4.2.2 WT PefR Protein Expression
LB media was prepared (10 g of tryptone, 10 g of NaCl, 5 g of yeast extract, 1 L of
Barnstead Diamond Nanopure water) in three 2 L flasks. The media was sterilized on a 20 min
cycle. After cooling to room temperature, 500 µL of 100 mM kanamycin stock solution was
added to each 2 L flask. To separate 125 mL flasks, 25 mL of the broth containing kanamycin
was extracted and inoculated with a WT PefR glycerol stock solution, using the sterile flame
loop technique. All flasks were incubated for approximately 18 h. The contents were then
returned to the 2 L flasks containing the remaining LB solution, to allow for growth on a larger
scale. Using a Varian 50 Bio UV-visible spectrophotometer, the optical density OD600 was
taken. The media was induced with 1 mL of 100 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG), once the absorbance reached an OD600 between 0.6 and 0.8 (approximately 4 h). The
temperature was reduced to 27 °C and the media continued shaking for another 18 h. The cells
were harvested using a JLA 8.100 rotor Beckman Coulter Avanti-T26 XPI centrifuge at 8,000 G
for 30 min at 4 °C. The cell pellet (15 g) was extracted and stored at 80 °C.
4.2.3 WT PefR Protein Purification
WT PefR cell pellet was placed in a beaker on ice containing buffer A (100 mM Tris-Cl
150 mM NaCl), 100 mM magnesium chloride, 10 mM phenylmethylsulfonyl fluoride, 10 mg/mL
lysozyme, 5 µg/mL each of DNase I Recombinant (Roche Diagnostics, Lot 14636800) and
RNase A (Roche Diagnostics, Lot 70297724) from bovine pancreas, and 500 mM NaCl. The
sample was lysed on ice for 30 min. The settings were set to 10 sec pulse on time and 10 sec
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pulse off time with an amplitude of 19%. Once lysed, the sample was centrifuged at 7000 rpm
for 45 min at 4 °C. The supernatant was collected and stored (-80 °C).
The purification steps were conducted at 4 °C using a GE Healthcare ÄKTA FPLC; all
buffer solutions were adjusted to pH 8.0. The sample (one Falcon tube) was loaded onto a StrepTactin Superflow column (5 mL, IBA BioTAGnology) equilibrated with buffer A (100 mM TrisHCl, 150 mM NaCl, pH 8.0). Unbound material was washed out with 5 column volumes (CV)
of buffer A. The protein was eluted with 10 CV of buffer B containing 100 mM Tris-HCl, 150
mM NaCl, 2.5 mM desthiobiotin, pH 8.0 applied via a linear gradient. This sample was stored in
the -80 °C freezer.
His-tagged PefR, purified from the construct developed in the Eichenbaum laboratory, 48
was a kind gift of BeiBei Liu from the laboratory for Dr. W. David Wilson.
4.2.4 Bradford Assay WT PefR
A 5 µM stock solution of bovine serum albumin was prepared in water. The
spectrophotometer was blanked with 200 µL of Coomassie Brilliant Blue G-250 dye (pre-made
solution from Thermo Scientific) and 800 µL water. Solutions of BSA from 0.012 to 0.06 µM
were prepared in duplicate. Dye (200 µL) was added to sample which was then incubated for 5
min. Spectra were taken and averaged for each concentration. A sample of PefR in water was
also treated similarly with Coomassie Brilliant Blue solution and the spectrum taken. Placement
of this point on the linear regression plot of the BSA was used to calculate the unknown
concentration.
4.2.5 Heme Titration of WT PefR
A 1 mL solution of WT PefR (5 μM as determined via Bradford Assay) was prepared in
buffer A (150 mM NaCl, 100 mM Tris-Cl at pH 8.0). The hemin solution was prepared by
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mixing 2 mg of hemin [ferriprotoporphyrin IX chloride (Fluka)] in 1 mL of DMSO. An
extinction coefficient of heme in DMSO was used (heme ɛ404 nm in DMSO 179 mM-1 cm-1) 78. A
1,000-fold dilution was made and a spectra taken to calculate the concentration of the stock,
solution which was 807 μM. The titration was carried out via a double cuvette system. One
quartz cuvette was used as the blank containing 1 mL buffer A. The second cuvette contained 1
mL of the 5 μM protein solution. To each cuvette was added 1 μL of the hemin solution every
15 min. The spectrum was taken of protein heme solution, using the heme-only solution as the
blank.
4.3

Results and Discussion
A construct of PefR with a Strep-tag was designed by Dr. Rizvan Uluisik and purchased

from Novagen (Figure 4.1). Transformation was performed and the resulting gene sequenced.
Figure 4.2 shows that the correct sequence was obtained.

Figure 4.1 Construct of PefR
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Figure 4.2 Sequence alignment of PefR showing proper transformation of plasmid in cell
line.
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It is common for transcription factors to be isolated bound to DNA. Early experiments in
our laboratory on PefR found this to be a significant issue. A study of successful transcription
factor purifications by Cyrianne Keutcha of our laboratory showed a high salt concentration (500
mM NaCl) was added to the lysing step in almost every instance (Table 4.1).
Table 4.1Puification techniques of DNA bound proteins.

Protein

Rv0678

MarR

PcaV

PI/ Aromatic
Residues

Lysis Buffer

Purification

Reference

5.69/(1W)(4Y)

200 mM sodium
chloride 20mM NaHEPES, pH 7.2 10
mM magnesium
chloride 0.2 mg of
DNase I

5 mL His-Trap Ni2+
chelating column (GE
Healthcare)

79

8.56/(1W)(1Y)

300 mM sodium
chloride 10%
glycerol 20 mM
Tris-HCl pH 7.5 1
mM PMSF 5 mM βmercaptoethanol

5 mL His-Trap column
(GE Healthcare)
Further purification
step using HiLoad
16/60 Superdex 200
column (GE
Healthcare)

9.65/(1W)((2Y)

500 mM sodium
chloride 50 mM
Tris-HCl 5 mM
imidazole 0.1%
Triton X-100

His-Trap HP Ni2+
affinity column (GE
Healthcare)

80

81

When this protocol was followed, pure protein was isolated after FPLC on a Streptactin column
as shown by SDS PAGE (Figure 4.3). Bradford analysis of the protein concentration allowed
calculation of a total of 2.32 mg of protein isolated from a 3 L culture.
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Heme proteins have a number of possible axial ligands, with His, Tyr, Met and Cys in
general the most common 82. Figure 4.4 highlights these resides in a homology model of PefR
based on the MepR x-ray structure of this transcription factor bound to DNA 83. The alignment
was obtained using I-TASSER 84.

Figure 4.3 SDS gel of WT PefR elution. Lane 1. Protein Ladder. Lane 2. Mixed Ladder
[BSA (66.5 kD), myoglobin (16.7 kD)). Lane 3-7. Fractions containing PefR.

Figure 4.4 I-TASSER model of PefR showing potential axial ligands
.
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The UV-visible absorbance spectrum (Figure 4.7) shows minimal heme loading. The extinction
coefficient of the 280 nm band is low in PefR (7,450 M-1 cm-1 as calculated from ExPASy 85)
because this protein has no tryptophans in the sequence, only a single Trp in the Strep-tag. A
useful rule of thumb is that the extinction coefficient of the heme in a heme protein is about 1 x
105 M-1 cm-1 at the Soret. Given this, the Soret/280 absorbance ratio of 0.05 indicates that the asisolated protein is about 5 % heme loaded. An expanded plot of the spectrum, (magnified 25
times) shows bands at 570, and 615 nm (Figure 4.7). These are consistent with a Cys axial
ligand, as discussed in more detail below.

Figure 4.5 UV-visible absorption spectra of WT PefR.

A heme titration was conducted for PefR, in which aliquots of hemin in DMSO were
added to two cuvettes, one with buffer only (blank) and one with a PefR solution. Figure 4.8
shows the absorbance as a function of the concentration of hemin. The absorbance of the Soret
at 390 nm increases as function of added hemin, with a break in the slope at 1.25. It is probable
that this indicates 1:1 hemin:protein binding, with the Bradford Assay not a completely reliable
indicator of the true protein concentration. It is also possible that the baseline increase at lower
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wavelengths, presumably due to light scattering is responsible for the discrepancy. The 390:280
nm absorbance ratio increases as the titration progresses, indicating hemin binding to the protein.
Figure 4.9 plots this ratio as a function of the concentration of hemin. Again, a break point in the
slopes is seen at a hemin:protein ration of about 1.25, consistent with the data plotted using the
390 nm absorbance.

Figure 4.6 Heme Titration of PefR. Protein (5 µM) was prepared in 100 mM Tris-Cl,
150 mM NaCl pH 8.0. Hemin in DMSO (1 µL of an 807µM stock) added every 15 min to both
the solution of PefR and a blank containing buffer only. Spectra are shown as a function of the
concentration of hemin.
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Figure 4.7 Absorbance at 390 nm as a function of the ratio of hemin to PefR.

Figure 4.8 Ratio of the 390 nm to 280 nm bands as a function of the ratio of hemin to
PefR
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A recent review on heme binding transcription factors details the observation that
cysteine (usually next to a proline) and histidine are the two most common ligands in hemebonding transcription factors 86. Cysteine alone as an axial ligand gives a Soret in the 370 – 390
nm region, as tabulated in work on the Bach 1 protein (Type 2) as shown in Table 4.2 87. In
general, histidine, either in 5-coordinate or 6-coordinate binding patterns, gives a Soret band >
405 nm. In model studies, H39G Mb bound to β-mercaptoethanol is a five-coordinate high-spin
ferric center with a Soret at 390 nm and small α,β bands around 510 nm 88. Both of these are true
for PefR. Thus, comparison of PefR spectra with literature data indicates that PefR has a Cys
heme ligand, consistent with other studies on heme-bound transcription factors 86.
Table 4.2 Comparison of Bach1 to other heme proteins. Taken from 87

Previous work on PefR used a His-tagged protein 89. Because histidine is an excellent ligand for
heme, there is a chance that it participates in binding to the heme of a His-tagged protein 76, 77.
Concerned about this possibility, we used a Strep-tagged construct. Figure 4.9 shows an overlay
of the two spectra, normalized to 1.0 at the Soret. The blue absorbance spectrum represents histagged PefR. There is a large Soret peak appearing at 407 nm. There is a shoulder peak at 350
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nm and α,β bands at 540 and 560, and 665 nm. This is a clear indication that the His-tag is
interfering with heme binding resulting in a completely different spectra.

Figure 4.9 UV-visible absorption spectra of WT PefR. The blue spectrum is his-tagged
PefR. The red spectrum is strep-tagged PefR.

To our knowledge, there is at present only one x-ray structure of a MarR transcription factor
bound to DNA, MepR from Staphylococcus aureus (PDB 4LLL) 83. Figure 4.11 shows this
structure with the residue homologous to PefR C106 (MepR I106) highlighted in blue. Heme
binding could then produce a significant change in the three-dimensional structure of the protein,
resulting in loss of DNA association when hemin binds to the protein. As an example of this
type of structure change on hemin binding is shown in Figure 4.10, in which the protein, HrtR,
without heme (and bound to DNA) has a significantly different three-dimensional structure than
the protein with heme bound (which does not bind to DNA) 86.
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Figure 4.10 WT HrtR in the apo form with DNA (left PDB 3VOK ) and holo form (right
PDB 3VP5) 90.

Figure 4.11 Crystal structure of S. aureus MepR bound to DNA 72. Highlighted in blue
is residue I106, which corresponds to C106 in PefR, the putative heme axial ligand.
Conclusions
The spectrum is consistent with a Cys axial ligand. Hemin titration experiments indicate
approximate 1:1 hemin:protein binding. Homology modeling predicts that C106 lies between
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two α-helices. Heme binding would be expected to alter the three-dimensional structure of the
protein significantly, allowing the expected pattern of the transcription factor binding to DNA
without heme and being released from DNA when heme is bound.
4.4

General Conclusions
Most bacteria require iron and many pathogenic bacteria use hemin as the main source of

iron during infections. Because free hemin is toxic, bacteria have developed regulatory
mechanisms to control the expression of proteins used in heme binding and transport. In Group
A Streptococcus, heme exposure results in a global transcriptome shift, up-regulating genes
involved in redox stress 48. Determining how heme-binding transcription factors control gene
expression is key in understanding the fundamental biochemistry of this pathway and may be
significant in developing new therapeutic approaches to combat disease caused by this organism.
Our studies on PefR reveal for the first time that this protein binds heme through a cysteine
ligand, and provide a basis in terms of spectral data and heme binding ratios for future work in
this area.
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